Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblasts

Summary Connective tissue growth factor (CTGF) plays a role in the fibrotic process of systemic sclerosis (SSc). Because hypoxia is associated with fibrosis in several profibrogenic conditions, we investigated whether CTGF expression in SSc fibroblasts is regulated by hypoxia. Dermal fibroblasts from patients with SSc and healthy controls were cultured in the presence of hypoxia or cobalt chloride (CoCl 2 ), a chemical inducer of hypoxia‐inducible factor (HIF)‐1α. Expression of CTGF was evaluated by Northern and Western blot analyses. Dermal fibroblasts exposed to hypoxia (1% O 2 ) or CoCl 2 (1–100 µM) enhanced expression of CTGF mRNA. Skin fibroblasts transfected with HIF‐1α showed the increased levels of CTGF protein and mRNA, as well as nuclear staining of HIF‐1α, which was enhanced further by treatment of CoCl 2 . Simultaneous treatment of CoCl 2 and transforming growth factor (TGF)‐β additively increased CTGF mRNA in dermal fibroblasts. Interferon‐γ inhibited the TGF‐β‐induced CTGF mRNA expression dose‐dependently in dermal fibroblasts, but they failed to hamper the CoCl 2 ‐induced CTGF mRNA expression. In addition, CoCl 2 treatment increased nuclear factor (NF)‐κB binding activity for CTGF mRNA, while decreasing IκBα expression in dermal fibroblasts . Our data suggest that hypoxia, caused possibly by microvascular alterations, up‐regulates CTGF expression through the activation of HIF‐1α in dermal fibroblasts of SSc patients, and thereby contributes to the progression of skin fibrosis.